Application of chlorogenic acid and compositions thereof in preparation of drugs for treating squamous cell carcinoma
US12194013B2 · kind B2 · utility
0Cited by
0References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 10, 2019 |
| Grant date | Jan 14, 2025 |
| Priority date | — |
| Expiry date | Mar 26, 2042 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Chlorogenic acid and/or coumaroylquinic acid are employed in preparation of drugs for treating squamous cell carcinoma. Chlorogenic acid or coumaroylquinic acid can effectively treat squamous cell carcinoma. A combination of chlorogenic acid and coumaroylquinic acid can also achieve effective treatment, can yield a synergistic effect, and has excellent application prospect.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.